About Teikoku Seiyaku
About
News
-
- 2025.6.11
- Promotion of joint educational activities on knee osteoarthritis
-
- 2025.3.27
- Change in The Board of Directors
-
- 2023.6.29
- President and CEO Misako Fujioka Interviewed in Newsweek International
-
- 2023.3.28
- Change in The Board of Directors
-
- 2023.3.15
- Notice of Launch of ALLYDONE® Patches 27.5 mg / ALLYDONE® Patches 55 mg in Japan as Japan’s First Donepezil Transdermal Therapeutic System
Company
Since our foundation over 170 years ago, Teikoku Seiyaku has used the transdermal technology we have cultivated to respond to and anticipate the needs of both patients and medical professionals.
View More